`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`MYLAN PHARMACEUTICALS INC., TEVA PHARMACEUTICALS USA,
`INC., and AKORN INC.
`Petitioners
`
`v.
`
`SAINT REGIS MOHAWK TRIBE and ALLERGAN, INC.
`Patent Owners
`____________________
`
`Case IPR2016-011291
`Patent 8,642,556
`____________________
`
`
`
`PETITIONER TEVA PHARMACEUTICALS USA, INC’S
` POWER OF ATTORNEY
`
`
`
`
`
`
`
`
`
`1 Cases IPR2017-00579 and IPR2017-00598 have been joined with this
`
`proceeding.
`
`
`
`
`
`Pursuant'tF37'CZFIR.—§_4271'0(B)TP€titimTtfileic—alsUSATInC.
`
`IPR2016-01129
`
`US. Patent No. 8,642,556
`
`hereby appoints the practitioners of Customer No. 26111 as its attorneys to transact
`
`all business in the United States Patent & Trademark Office and Patent Trial and
`
`Appeal Board associated with the above~captioned inter partes review of US.
`
`Patent No. 8,642,556. These practitioners include at least:
`
`Ralph Wilson Powers 111 (Registration No. 63,504)
`
`Address
`
`STERNE, KESSLER, GOLDSTEIN & Fox P.L.L.C.
`
`1 100 New York Avenue, NW
`
`Washington, DC 20005
`
`202.371 .2600 (reception)
`
`202.371.2540 (facsimile)
`
`
`FOR: Teva Pharmaceuticals USA Inc.
`
`SIGNATURE:
`BY: Rik/K5
`
`If“.
`
`[Wt/R 1% '
`jumgm’iis
`
`